GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PixarBio Corp (GREY:PXRB) » Definitions » Notes Receivable

PixarBio (PixarBio) Notes Receivable : $0.00 Mil (As of Sep. 2016)


View and export this data going back to 2016. Start your Free Trial

What is PixarBio Notes Receivable?

PixarBio's Notes Receivable for the quarter that ended in Sep. 2016 was $0.00 Mil.


PixarBio Notes Receivable Historical Data

The historical data trend for PixarBio's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PixarBio Notes Receivable Chart

PixarBio Annual Data
Trend Dec14 Dec15
Notes Receivable
- -

PixarBio Quarterly Data
Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16
Notes Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

PixarBio Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.


PixarBio Notes Receivable Related Terms

Thank you for viewing the detailed overview of PixarBio's Notes Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


PixarBio (PixarBio) Business Description

Traded in Other Exchanges
N/A
Address
200 Boston Avenue, Suite 1875, Medford, MA, USA, 02155
PixarBio Corp is a specialty pharmaceutical company focused on preclinical and clinical commercial development of therapeutic drug delivery systems for post-operative pain. The company's lead clinical candidate, NeuroRelease is a non-opioid / non-opiate preclinical stage product intended for the treatment of surgical pain, with planned future indications for chronic pain. NeuroRelease blocks nociceptive and neuropathic pain signals arising from temperature and pressure stimuli without affecting motor function, which is intended to allow for effective treatment without delaying post-surgical physical therapy.

PixarBio (PixarBio) Headlines